Add BrightSurf on Google Email

University of Birmingham


Immune ageing detected in the earliest stages of rheumatoid arthritis before clinical diagnosis gives hope for early intervention

A new study from the University of Birmingham has found that immune ageing may be a driver of rheumatoid arthritis rather than a consequence of the disease. The research detected features of immune system ageing in the earliest stages of RA, even before clinical diagnosis, suggesting that early intervention is possible.

SourceUniversity of Birmingham·JournalEBioMedicine·DateSep 8, 2025

Global methane levels continue rising as planet heats up

Methane emissions from global trade have risen by 30% since 1990, driven by rapid industrialization and population growth in Asia and the developing Pacific region. The study calls for targeted sectoral strategies to reduce emissions, including advanced leak detection and improved livestock feed formulations.

SourceUniversity of Birmingham·JournalNature Communications·TypeData/statistical analysis·DateSep 3, 2025

Therapeutic potential for PEPITEM in osteoporosis

Researchers from the University of Birmingham identified bioactive peptide sequences in PEPITEM that counteract key changes caused by osteoporosis. The study shows the full PEPITEM molecule reduces bone resorption, increases bone formation, and promotes angiogenesis in bone.

SourceUniversity of Birmingham·JournalBiomedicine & Pharmacotherapy·TypeExperimental study·DateSep 2, 2025

Beyond the trip: How compounds derived from psychedelics could help treat inflammatory conditions

Researchers have identified a new class of compounds derived from psychedelics that could open the door to safe, targeted therapies for widespread use in clinical settings. These PIPI drugs may modulate the immune system to control inflammation, potentially treating conditions such as Alzheimer's and Parkinson's disease.

SourceUniversity of Birmingham·JournalBritish Journal of Pharmacology·TypeLiterature review·DateSep 1, 2025

Adding cell-based vaccine to liver cancer therapy slows cancer progression in patients with liver cancer

A new study found that a cell-based vaccine using dendritic cells can improve progression-free survival time for patients with intermediate-stage primary liver cancer. The ImmunoTACE trial showed an average of 18 months of tumor progression compared to 10 months in the control group.

SourceUniversity of Birmingham·JournalClinical Cancer Research·TypeRandomized controlled/clinical trial·DateAug 26, 2025

Probiotics for preterm babies lowered antibiotic resistant bacteria in gut, new study shows

A new study found that probiotics significantly reduced the presence of antibiotic-resistant bacteria and multidrug-resistant bacteria in the infant gut, while also promoting a more typical gut microbiome. This breakthrough has major implications for the global AMR crisis, particularly for preterm infants.

SourceUniversity of Birmingham·JournalNature Communications·TypeExperimental study·DateAug 15, 2025

Rise in expectant mothers in UK with autoimmune diseases since millennium

A recent study published in Lancet Rheumatology found a significant increase in autoimmune conditions among pregnant women in the UK since the millennium. The research analyzed electronic healthcare records from 2000-2021 and discovered a 4.7% rise in expectant mothers beginning pregnancy with autoimmune diseases, including psoriasis, ...

SourceUniversity of Birmingham·JournalThe Lancet Rheumatology·TypeData/statistical analysis·DateJun 2, 2025

Household action can play major role in climate change fight - study

A new study found that adopting low-carbon lifestyles can reduce global carbon footprints by 10.4 gigatons of CO2 equivalent, equivalent to 40.1% of household consumption-based emissions in 116 countries analysed. Researchers identified 21 low-carbon actions that could achieve this reduction if adopted by the top 23.7% of global emitters.

SourceUniversity of Birmingham·JournalNature Communications·TypeObservational study·DateMay 20, 2025